Privia Health Group Inc (NAS:PRVA)
$ 21.16 +0.015 (+0.07%) Market Cap: 2.70 Bil Enterprise Value: 2.35 Bil PE Ratio: 100.74 PB Ratio: 3.41 GF Score: 88/100

Q4 2024 Privia Health Group Inc Earnings Call Transcript

Feb 27, 2025 / 01:00PM GMT
Release Date Price: $25.46 (+5.82%)

Key Points

Positve
  • Privia Health Group Inc (PRVA) exceeded the high end of all guidance metrics for 2024, showcasing strong performance across all markets.
  • Implemented providers increased by 11.2% year over year, driving a 13.6% growth in FIA service collections.
  • Adjusted EBITDA rose by 25.2%, with operating leverage contributing to a 230 basis point margin expansion year over year.
  • The company generated a record $109.3 million in free cash flow in 2024, converting 121% of adjusted EBITDA.
  • Privia Health Group Inc (PRVA) ended the year with $491 million in cash and no debt, providing significant financial flexibility.
Negative
  • Privia Health Group Inc (PRVA) anticipates headwinds in the Medicare Advantage environment over the next few years due to elevated utilization trends and changes in star scores.
  • The company expects minimal increase in shared savings accruals year over year, given ongoing challenges in the Medicare Advantage environment.
  • The guidance for 2025 assumes no new business development activity or capital deployment, potentially limiting growth opportunities.
  • Privia Health Group Inc (PRVA) is nearing the end of its net operating loss carry forward, which will result in higher cash taxes in 2025.
  • The company faces a challenging environment for value-based care entities, with revisions in estimates and performance both publicly and in the private market.
Operator

Thank you for standing by. My name is Luella, and I will be your conference operator today. At this time, I would like to welcome everyone to the Privia Health fourth quarter conference call.

(Operator Instructions)

Thank you. Please be advised that today's conference is being recorded. I would now like to turn the conference over to Robert Borchard, SVP of Investor and Corporate communication. Please go ahead, sir.

Robert Borchert Privia Health Group Inc;Investment Relator

Thank you, Luella, and good morning, everyone. Joining me are Parth Mehrotra, our Chief Executive Officer, and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed the investor relations section of Prviahealth.com along with today's financial press release and slide presentation. Following our prepared comments, we will open the line for questions and we ask that you please limit yourself to one question only and return to the queue if you have a follow up so we can get to as many questions as possible.

The

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot